IDH1 and central nervous system cancer: As of 2016, gliomas are divided into circumscribed gliomas (WHO grade I) and diffusely infiltrating gliomas (WHO grades II-IV) based on their pattern of growth and the IDH mutation status (Lapointe et al., 2018).